A sensitive liquid chromatography and mass spectrometry method for the determination of posaconazole in human plasma
- 4 January 2007
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 43 (1), 228-236
- https://doi.org/10.1016/j.jpba.2006.06.011
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Posaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other ConditionsClinical Infectious Diseases, 2006
- Effect of a Nutritional Supplement on Posaconazole Pharmacokinetics following Oral Administration to Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2006
- A Multicenter Randomized Trial Evaluating Posaconazole versus Fluconazole for the Treatment of Oropharyngeal Candidiasis in Subjects with HIV/AIDSClinical Infectious Diseases, 2006
- Posaconazole Is Effective as Salvage Therapy in Zygomycosis: A Retrospective Summary of 91 CasesClinical Infectious Diseases, 2006
- Pharmacokinetics, Safety, and Efficacy of Posaconazole in Patients with Persistent Febrile Neutropenia or Refractory Invasive Fungal InfectionAntimicrobial Agents and Chemotherapy, 2006
- Posaconazole as Salvage Therapy for ZygomycosisAntimicrobial Agents and Chemotherapy, 2006
- PosaconazoleDrugs, 2005
- Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infectionsInternational Journal Of Clinical Practice, 2004
- Pharmacokinetics of Posaconazole Coadministered with Antacid in Fasting or Nonfasting Healthy MenAntimicrobial Agents and Chemotherapy, 2004
- Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adultsBritish Journal of Clinical Pharmacology, 2003